569 related articles for article (PubMed ID: 20675343)
41. MicroRNA-183 is involved in cell proliferation, survival and poor prognosis in pancreatic ductal adenocarcinoma by regulating Bmi-1.
Zhou L; Zhang WG; Wang DS; Tao KS; Song WJ; Dou KF
Oncol Rep; 2014 Oct; 32(4):1734-40. PubMed ID: 25109303
[TBL] [Abstract][Full Text] [Related]
42. Circulating microRNAs in serum of human K-ras oncogene transgenic rats with pancreatic ductal adenocarcinomas.
Yabushita S; Fukamachi K; Tanaka H; Sumida K; Deguchi Y; Sukata T; Kawamura S; Uwagawa S; Suzui M; Tsuda H
Pancreas; 2012 Oct; 41(7):1013-8. PubMed ID: 22513294
[TBL] [Abstract][Full Text] [Related]
43. A genetically engineered mouse model developing rapid progressive pancreatic ductal adenocarcinoma.
Yamaguchi T; Ikehara S; Nakanishi H; Ikehara Y
J Pathol; 2014 Oct; 234(2):228-38. PubMed ID: 25042889
[TBL] [Abstract][Full Text] [Related]
44. Role of miR-30a-3p Regulation of Oncogenic Targets in Pancreatic Ductal Adenocarcinoma Pathogenesis.
Shimomura H; Okada R; Tanaka T; Hozaka Y; Wada M; Moriya S; Idichi T; Kita Y; Kurahara H; Ohtsuka T; Seki N
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899691
[TBL] [Abstract][Full Text] [Related]
45. EP300--a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas.
Mees ST; Mardin WA; Wendel C; Baeumer N; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
Int J Cancer; 2010 Jan; 126(1):114-24. PubMed ID: 19569050
[TBL] [Abstract][Full Text] [Related]
46. Loss of histone demethylase KDM6B enhances aggressiveness of pancreatic cancer through downregulation of C/EBPα.
Yamamoto K; Tateishi K; Kudo Y; Sato T; Yamamoto S; Miyabayashi K; Matsusaka K; Asaoka Y; Ijichi H; Hirata Y; Otsuka M; Nakai Y; Isayama H; Ikenoue T; Kurokawa M; Fukayama M; Kokudo N; Omata M; Koike K
Carcinogenesis; 2014 Nov; 35(11):2404-14. PubMed ID: 24947179
[TBL] [Abstract][Full Text] [Related]
47. MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors.
Jiao LR; Frampton AE; Jacob J; Pellegrino L; Krell J; Giamas G; Tsim N; Vlavianos P; Cohen P; Ahmad R; Keller A; Habib NA; Stebbing J; Castellano L
PLoS One; 2012; 7(2):e32068. PubMed ID: 22384141
[TBL] [Abstract][Full Text] [Related]
48. A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells.
Kent OA; Mullendore M; Wentzel EA; López-Romero P; Tan AC; Alvarez H; West K; Ochs MF; Hidalgo M; Arking DE; Maitra A; Mendell JT
Cancer Biol Ther; 2009 Nov; 8(21):2013-24. PubMed ID: 20037478
[TBL] [Abstract][Full Text] [Related]
49. Long noncoding RNA MIR31HG exhibits oncogenic property in pancreatic ductal adenocarcinoma and is negatively regulated by miR-193b.
Yang H; Liu P; Zhang J; Peng X; Lu Z; Yu S; Meng Y; Tong WM; Chen J
Oncogene; 2016 Jul; 35(28):3647-57. PubMed ID: 26549028
[TBL] [Abstract][Full Text] [Related]
50. PIN1 Maintains Redox Balance via the c-Myc/NRF2 Axis to Counteract Kras-Induced Mitochondrial Respiratory Injury in Pancreatic Cancer Cells.
Liang C; Shi S; Liu M; Qin Y; Meng Q; Hua J; Ji S; Zhang Y; Yang J; Xu J; Ni Q; Li M; Yu X
Cancer Res; 2019 Jan; 79(1):133-145. PubMed ID: 30355620
[TBL] [Abstract][Full Text] [Related]
51. miR-186 and 326 predict the prognosis of pancreatic ductal adenocarcinoma and affect the proliferation and migration of cancer cells.
Zhang ZL; Bai ZH; Wang XB; Bai L; Miao F; Pei HH
PLoS One; 2015; 10(3):e0118814. PubMed ID: 25742499
[TBL] [Abstract][Full Text] [Related]
52. A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signalling.
Kong B; Wu W; Cheng T; Schlitter AM; Qian C; Bruns P; Jian Z; Jäger C; Regel I; Raulefs S; Behler N; Irmler M; Beckers J; Friess H; Erkan M; Siveke JT; Tannapfel A; Hahn SA; Theis FJ; Esposito I; Kleeff J; Michalski CW
Gut; 2016 Apr; 65(4):647-57. PubMed ID: 25601637
[TBL] [Abstract][Full Text] [Related]
53. Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma.
Bhatti I; Lee A; James V; Hall RI; Lund JN; Tufarelli C; Lobo DN; Larvin M
J Gastrointest Surg; 2011 Jan; 15(1):199-208. PubMed ID: 21088996
[TBL] [Abstract][Full Text] [Related]
54. Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1.
Wang P; Chen L; Zhang J; Chen H; Fan J; Wang K; Luo J; Chen Z; Meng Z; Liu L
Oncogene; 2014 Jan; 33(4):514-24. PubMed ID: 23334332
[TBL] [Abstract][Full Text] [Related]
55. WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC.
Pan Y; Lu F; Xiong P; Pan M; Zhang Z; Lin X; Pan M; Huang H
J Exp Clin Cancer Res; 2018 Jul; 37(1):167. PubMed ID: 30041660
[TBL] [Abstract][Full Text] [Related]
56. MiR-7-5p functions as a tumor suppressor by targeting SOX18 in pancreatic ductal adenocarcinoma.
Zhu W; Wang Y; Zhang D; Yu X; Leng X
Biochem Biophys Res Commun; 2018 Mar; 497(4):963-970. PubMed ID: 29408481
[TBL] [Abstract][Full Text] [Related]
57. SOX2 functions as a molecular rheostat to control the growth, tumorigenicity and drug responses of pancreatic ductal adenocarcinoma cells.
Wuebben EL; Wilder PJ; Cox JL; Grunkemeyer JA; Caffrey T; Hollingsworth MA; Rizzino A
Oncotarget; 2016 Jun; 7(23):34890-906. PubMed ID: 27145457
[TBL] [Abstract][Full Text] [Related]
58. Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer.
Sun Y; Peng W; He W; Luo M; Chang G; Shen J; Zhao X; Hu Y
J Exp Clin Cancer Res; 2018 Jul; 37(1):166. PubMed ID: 30041673
[TBL] [Abstract][Full Text] [Related]
59. Identification of miR-143 as a tumour suppressor in nasopharyngeal carcinoma based on microRNA expression profiling.
Xu YF; Li YQ; Guo R; He QM; Ren XY; Tang XR; Jia WH; Kang TB; Zeng MS; Sun Y; Ma J; Liu N
Int J Biochem Cell Biol; 2015 Apr; 61():120-8. PubMed ID: 25701793
[TBL] [Abstract][Full Text] [Related]
60. MiR-371-5p facilitates pancreatic cancer cell proliferation and decreases patient survival.
He D; Miao H; Xu Y; Xiong L; Wang Y; Xiang H; Zhang H; Zhang Z
PLoS One; 2014; 9(11):e112930. PubMed ID: 25411783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]